MAPT and Alzheimer disease: Thus, phosphatases influence Tau phosphorylation through several mechanisms, and in a pathological condition such as AD where phosphatase activity is decreased (Liu et al., 2005), these enzymes are key factors in the development of the disease (Figure 1).